Stockreport

Lilly's Foundayo lowers heart attack, stroke risk in study [USA TODAY]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The U.S. Food and Drug Administration approved the pill, Foundayo, for weight loss earlier this month, intensifying Lilly's competition with Danish rival Novo Nordisk N [Read more]